IRD
Price
$1.87
Change
-$0.14 (-6.97%)
Updated
Oct 17 closing price
Capitalization
112.03M
Intraday Buy/Sell Signals
RLYB
Price
$0.54
Change
-$0.01 (-1.82%)
Updated
Oct 17 closing price
Capitalization
22.36M
19 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

IRD vs RLYB

Header iconIRD vs RLYB Comparison
Open Charts IRD vs RLYBBanner chart's image
Opus Genetics
Price$1.87
Change-$0.14 (-6.97%)
Volume$367.92K
Capitalization112.03M
Rallybio
Price$0.54
Change-$0.01 (-1.82%)
Volume$102.6K
Capitalization22.36M
IRD vs RLYB Comparison Chart in %
IRD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLYB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IRD vs. RLYB commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IRD is a Hold and RLYB is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 19, 2025
Stock price -- (IRD: $1.87 vs. RLYB: $0.54)
Brand notoriety: IRD and RLYB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IRD: 99% vs. RLYB: 30%
Market capitalization -- IRD: $112.03M vs. RLYB: $22.36M
IRD [@Biotechnology] is valued at $112.03M. RLYB’s [@Biotechnology] market capitalization is $22.36M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IRD’s FA Score shows that 0 FA rating(s) are green whileRLYB’s FA Score has 1 green FA rating(s).

  • IRD’s FA Score: 0 green, 5 red.
  • RLYB’s FA Score: 1 green, 4 red.
According to our system of comparison, both IRD and RLYB are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IRD’s TA Score shows that 2 TA indicator(s) are bullish while RLYB’s TA Score has 4 bullish TA indicator(s).

  • IRD’s TA Score: 2 bullish, 6 bearish.
  • RLYB’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, RLYB is a better buy in the short-term than IRD.

Price Growth

IRD (@Biotechnology) experienced а -4.59% price change this week, while RLYB (@Biotechnology) price change was +4.74% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.56%. For the same industry, the average monthly price growth was +15.88%, and the average quarterly price growth was +79.09%.

Reported Earning Dates

RLYB is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (+1.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IRD($112M) has a higher market cap than RLYB($22.4M). IRD YTD gains are higher at: 57.143 vs. RLYB (-44.260). RLYB has higher annual earnings (EBITDA): -43.29M vs. IRD (-61.46M). RLYB has more cash in the bank: 45.7M vs. IRD (32.4M). RLYB has less debt than IRD: RLYB (58K) vs IRD (1M). IRD has higher revenues than RLYB: IRD (15.4M) vs RLYB (761K).
IRDRLYBIRD / RLYB
Capitalization112M22.4M500%
EBITDA-61.46M-43.29M142%
Gain YTD57.143-44.260-129%
P/E RatioN/AN/A-
Revenue15.4M761K2,024%
Total Cash32.4M45.7M71%
Total Debt1M58K1,724%
FUNDAMENTALS RATINGS
IRD: Fundamental Ratings
IRD
OUTLOOK RATING
1..100
24
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
99
SEASONALITY SCORE
1..100
26

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IRDRLYB
RSI
ODDS (%)
Bearish Trend 2 days ago
82%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
85%
MACD
ODDS (%)
Bearish Trend 2 days ago
84%
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 11 days ago
81%
Bullish Trend 4 days ago
88%
Declines
ODDS (%)
Bearish Trend 9 days ago
85%
Bearish Trend 9 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
IRD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLYB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LTRBF0.03N/A
N/A
LATROBE MAGNESIUM LTD.
CMBNF91.31N/A
N/A
CEMBRA MONEY BK AG
ILXP0.02N/A
N/A
International Luxury Products, Inc.
GNENY5.40-0.10
-1.82%
Ganfeng Lithium Group Co. Ltd.
CRLBF1.22-0.11
-8.34%
Cresco Labs Inc.

IRD and

Correlation & Price change

A.I.dvisor indicates that over the last year, IRD has been loosely correlated with ARRY. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if IRD jumps, then ARRY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRD
1D Price
Change %
IRD100%
-6.97%
ARRY - IRD
35%
Loosely correlated
-0.17%
RLYB - IRD
33%
Loosely correlated
-3.39%
GANX - IRD
33%
Poorly correlated
+3.31%
TERN - IRD
33%
Poorly correlated
-2.32%
MURA - IRD
32%
Poorly correlated
N/A
More